A spin-off company from TRIUMF, Canada’s particle accelerator centre, has been acquired by Australian biopharma company Telix Pharmaceuticals. Vancouver’s ARTMS, an innovator in the medical isotopes space, was acquired in a recent US$82 million deal. “ARTMS is a tremendous example of how federal support for fundamental science can spur innovation and deliver real impact for […]
ARTMS
ARTMS Raises $19 Million For Work On Diagnostic Imaging Isotopes
Vancouver’s ARTMS has raised US$19 million in a Series A financing round led by New York based Deerfield Management Company with continued investment from Vancouver based seed investor Global Health Science (GHS) Fund. ARTMS’s flagship product, the QUANTM Irradiation System® (QIS®), provides for cost-effective, decentralized, and local production of important medical isotopes, such as Gallium-68, Zirconium-89, […]